Trial · NCT05137054
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Incidence of Dose Limiting Toxicities (DLTs) for each study regimen during the observation period | Up to 28 Days | Dose finding portion only |
| Primary | Incidence of Treatment-Emergent Adverse Events (TEAEs) | Up to 5 Years | |
| Primary | Severity of TEAEs | Up to 5 Years | |
| Primary | Incidence of Serious Adverse Events (SAEs) | Up to 5 Years | |
| Primary | Severity of SAEs | Up to 5 Years | |
| Primary | Incidence of Adverse Events of Special Interest (AESIs) | Up to 5 Years | |
| Primary | Severity of AESIs | Up to 5 Years | |
| Primary | Incidence of laboratory abnormalities | Up to 5 Years | ≥ grade 3 per National Cancer Institute-Common Terminology Criteria for Adverse Events \[NCI-CTCAE v5.0\] |
| Secondary | Overall Response Rate (ORR) as measured by International Myeloma Working Group (IMWG) criteria | Up to 5 Years | |
| Secondary | Duration of Response (DOR) by IMWG criteria | Up to 5 Years | |
| Secondary | Progression-Free Survival (PFS) as measured by IMWG criteria | Up to 5 Years | |
| Secondary | Rate of Minimal Residual Disease (MRD) negative status by IMWG criteria | Up to 5 Years | |
| Secondary | Concentrations of total linvoseltamab in serum over time | Up to 5 Years | |
| Secondary | Incidence over time of Anti-Drug Antibodies (ADAs) to linvoseltamab | Up to 5 Years | |
| Secondary | Overall Survival (OS) | Up to 5 Years |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05137054/registered